Peak Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-383
Closed -$296K 151
2024
Q4
$296K Hold
383
0.05% 123
2024
Q3
$339K Hold
383
0.06% 117
2024
Q2
$347K Hold
383
0.07% 112
2024
Q1
$298K Sell
383
-61
-14% -$43.4K 0.06% 123
2023
Q4
$259K Buy
444
+29
+7% +$16.9K 0.06% 126
2023
Q3
$223K Buy
+415
New +$214K 0.05% 130

Other funds holding LLY

Peak Asset Management's LLY Position: Q1 2025 in Review

Peak Asset Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 383 shares — an estimated $296K sold.

Peak Asset Management first reported a position in LLY in Q3 2023 and held it in 6 quarters. The position peaked at $347K in Q2 2024. 3,927 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Peak Asset Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Peak Asset Management sold 383 Eli Lilly shares in Q1 2025, an estimated $296K.
  • Peak Asset Management first reported a position in Eli Lilly in Q3 2023 and held it in 6 quarters.
  • Peak Asset Management's Eli Lilly position peaked at $347K in Q2 2024.
  • 3,927 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Peak Asset Management's 13F filing for Q1 2025, filed 7 May 2025.